Special Combination of OBP-301 and Pembrolizumab

Clinical trial NCT03172819 · COMPLETED

Trial details

NCT number: NCT03172819
Sponsor: Toshihiko Doi
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Advanced Solid Tumor

Start date: 2017-10-01
Primary completion: 2021-04-06
Enrollment: 22

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.